Legacy Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$491K Buy
4,386
+522
+14% +$53.9K 0.05% 265
2024
Q4
$357K Buy
3,864
+870
+29% +$78.3K 0.03% 289
2024
Q3
$251K Buy
+2,994
New +$228K 0.03% 326
2024
Q1
Sell
-2,668
Closed -$216K 322
2023
Q4
$216K Buy
+2,668
New +$208K 0.03% 287
2021
Q1
Sell
-5,416
Closed -$316K 124
2020
Q4
$316K Hold
5,416
0.18% 81
2020
Q3
$342K Sell
5,416
-584
-10% -$40.5K 0.23% 72
2020
Q2
$462K Buy
+6,000
New +$460K 0.37% 56
2019
Q3
Sell
-550
Closed -$37K 193
2019
Q2
$37K Buy
+550
New +$36.2K 0.03% 222
2018
Q4
Sell
-130
Closed -$10K 219
2018
Q3
$10K Hold
130
﹤0.01% 349
2018
Q2
$9K Buy
130
+55
+73% +$3.88K 0.01% 312
2018
Q1
$6K Hold
75
﹤0.01% 295
2017
Q4
$5K Hold
75
﹤0.01% 299
2017
Q3
$6K Hold
75
0.01% 265
2017
Q2
$5K Hold
75
0.01% 179
2017
Q1
$5K Sell
75
-355
-83% -$25K 0.01% 171
2016
Q4
$30K Buy
+430
New +$32K 0.04% 128

Other funds holding GILD

Legacy Advisors's GILD Position: Q1 2025 in Review

Legacy Advisors increased its Gilead Sciences (GILD) stake by 14% in Q1 2025, buying an estimated $53.9K and bringing the position to 4,386 shares worth $491K. The position accounts for 0.05% of the portfolio, ranked #265.

Legacy Advisors first reported a position in GILD in Q4 2016 and has held it in 16 quarters since. 2,019 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Legacy Advisors held 4,386 shares of Gilead Sciences worth $491K as of Q1 2025.
  • Legacy Advisors bought 522 Gilead Sciences shares in Q1 2025, an estimated $53.9K.
  • Gilead Sciences made up 0.05% of Legacy Advisors's portfolio in Q1 2025, its #265 holding.
  • Legacy Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 16 quarters since.
  • 2,019 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.